Metabolomics has ushered in a novel and multi-disciplinary realm in biological research. It
has provided researchers with a platform to combine powerful biochemical, statistical …

The Plasmodium parasite, the causative agent of malaria, is an excellent model for
immunomic-based approaches to vaccine development. The Plasmodium parasite has a …

An effective blood-stage vaccine against Plasmodium falciparum remains a research
priority, but the number of antigens that have been translated into multicomponent vaccines …

The lack of an effective licensed vaccine remains one of the most significant gaps in the
portfolio of tools being developed to eliminate Plasmodium falciparum malaria. Vaccines …

Malaria, an infectious disease caused by parasites of the Plasmodium genus, is one of the
world's major public health concerns causing up to a million deaths annually, mostly …

Plasmodium falciparum, the cause of almost all human malaria mortality, is a member of the
Laverania subgenus which infects African great apes. Interestingly, Laverania parasites …

There is an urgent need for the development of new antimalarial drugs with novel modes of
actions. The malarial parasite, Plasmodium falciparum, has a relatively small kinome of< …

Inclusion of affinity tags has greatly facilitated process development for protein antigens,
primarily for their recovery from complex mixtures. Although generally viewed as supportive …

Although epidemiological observations, IgG passive transfer studies and experimental
infections in humans all support the feasibility of developing highly effective malaria …

Plasmodium vivax pre-erythrocytic (PE) vaccine research has lagged far behind efforts to
develop Plasmodium falciparum vaccines. There is a critical gap in our knowledge of PE …